Examining the quality of life in patients with Heart Failure and the effect of sertraline drug prescription on the quality of life of these patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241103063574N1

Enrollment

Registered

2024-11-06

Start date

2024-12-06

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure. Heart failure, unspecified

Interventions

Intervention 1: Intervention group: patients with heart failure referring to the heart clinic of Kosar Semnan Hospital, whose ventricular ejection fraction (EF) is less than 40% in the echocardiograph

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: EF Less than 40%

Exclusion criteria

Exclusion criteria: Using sertraline previously Known case for psychiatric disease

Design outcomes

Primary

Measure	Time frame
Quality of life. Timepoint: The beginning of the study and 4 weeks later. Method of measurement: MLHFQ (Minnesota LIVING WITH HEART FAILURE Questionnaire ).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamira Mehrabi Pari

Semnan University of Medical Sciences

drmehrabipari@gmail.com+98 23 3349 0749

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026